XML 34 R23.htm IDEA: XBRL DOCUMENT v3.25.3
BUSINESS ACQUISITIONS AND DISPOSITIONS (Tables)
 9 Months Ended
Sep. 30, 2025
Business Combination [Abstract]  
Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]
The purchase price allocations for these acquisitions were preliminary at September 30, 2025. The valuation of acquired assets and assumed liabilities included the following:
BioReference HealthOther Business Acquisitions Closed During the Nine Months Ended September 30, 2025Measurement Period Adjustments During the Nine Months Ended September 30, 2025Amounts Acquired During the Nine Months Ended September 30, 2025
Property, plant, and equipment
$— $0.2 $(0.8)$(0.6)
Goodwill105.8 74.1 16.8 196.7 
Intangible assets119.2 83.7 (16.0)186.9 
Total assets acquired225.0 158.0 — 383.0 
Accrued expenses and other— 24.0 — 24.0 
Other liabilities32.5 2.5 — 35.0 
Total liabilities acquired32.5 26.5 — 59.0 
Net assets acquired192.5 131.5 — 324.0 
Cash paid for acquisitions$192.5 $131.5 $— $324.0 
Business Combination, Pro Forma Information [Table Text Block]
Had the aggregate of the Company’s 2025 and 2024 acquisitions, that were accounted for as business combinations, been completed at January 1, 2024, the Company’s unaudited pro forma results would have been as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Revenues$3,589.6 $3,368.4 $10,531.6 $10,065.6 
Net earnings attributable to LHI$266.1 $181.1 $728.1 $640.9